We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Fast Track Designation for Primary Liver Cancer Treatment

News   May 19, 2014

 
FDA Fast Track Designation  for Primary Liver Cancer Treatment
 
 
 

RELATED ARTICLES

A Sweet Surprise: Targeting Sugar-coated Proteins to Treat Pancreatitis

News

CA19-9 – a complex sugar structure that coats many proteins, has now been linked to the transformation of pancreatitis to pancreatic cancer, according to a new study published in Science.

READ MORE

Sickle Cell Drug IMR-687 Shows Promise in Clinical Trial

News

An investigational drug for the treatment of sickle cell disease shows early promise in Phase 2a clinical trial. The orally administered drug, given to adult patients with sickle cell disease, is demonstrating tolerability and the ability to impact both red and white blood cell biomarkers of the disease.

READ MORE

A New Role for Cohesin Protein in Tumors and Rare Diseases?

News

Cohesin mutations have been identified in some types of cancer and in rare diseases referred to as cohesinopathies. Now, scientsits describe new functions of cohesin in mouse embryonic stem cells that might help understand and address the causes of these disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE